Proactiveinvestors Australia SUDA Pharmaceuticals Ltd https://www.proactiveinvestors.com.au Proactiveinvestors Australia SUDA Pharmaceuticals Ltd RSS feed en Sun, 27 Sep 2020 15:24:50 +1000 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) SUDA Pharmaceuticals anagrelide oral spray formulation supported by new study results https://www.proactiveinvestors.com.au/companies/news/929605/suda-pharmaceuticals-anagrelide-oral-spray-formulation-supported-by-new-study-results-929605.html Tue, 22 Sep 2020 00:39:00 +1000 https://www.proactiveinvestors.com.au/companies/news/929605/suda-pharmaceuticals-anagrelide-oral-spray-formulation-supported-by-new-study-results-929605.html SUDA Pharmaceuticals secures Australia patent for Anagrelide cancer treatment, shares up 28% https://www.proactiveinvestors.com.au/companies/news/928451/suda-pharmaceuticals-secures-australia-patent-for-anagrelide-cancer-treatment-shares-up-28-928451.html Tue, 08 Sep 2020 01:50:00 +1000 https://www.proactiveinvestors.com.au/companies/news/928451/suda-pharmaceuticals-secures-australia-patent-for-anagrelide-cancer-treatment-shares-up-28-928451.html SUDA Pharmaceuticals appoints public company specialist Phillip Hains as company secretary https://www.proactiveinvestors.com.au/companies/news/926880/suda-pharmaceuticals-appoints-public-company-specialist-phillip-hains-as-company-secretary-926880.html Tue, 18 Aug 2020 05:08:00 +1000 https://www.proactiveinvestors.com.au/companies/news/926880/suda-pharmaceuticals-appoints-public-company-specialist-phillip-hains-as-company-secretary-926880.html SUDA Pharmaceuticals chairman shows faith in pharmaceutical strategy by entitlement offer participation https://www.proactiveinvestors.com.au/companies/news/926086/suda-pharmaceuticals-chairman-shows-faith-in-pharmaceutical-strategy-by-entitlement-offer-participation-926086.html Fri, 07 Aug 2020 04:18:00 +1000 https://www.proactiveinvestors.com.au/companies/news/926086/suda-pharmaceuticals-chairman-shows-faith-in-pharmaceutical-strategy-by-entitlement-offer-participation-926086.html SUDA Pharmaceuticals completes entitlement offer to raise $3.56 million https://www.proactiveinvestors.com.au/companies/news/925852/suda-pharmaceuticals-completes-entitlement-offer-to-raise-356-million-925852.html Wed, 05 Aug 2020 04:02:00 +1000 https://www.proactiveinvestors.com.au/companies/news/925852/suda-pharmaceuticals-completes-entitlement-offer-to-raise-356-million-925852.html SUDA Pharmaceuticals closes $3.56 million entitlement offer heavily oversubscribed https://www.proactiveinvestors.com.au/companies/news/925641/suda-pharmaceuticals-closes-356-million-entitlement-offer-heavily-oversubscribed-925641.html Mon, 03 Aug 2020 04:25:00 +1000 https://www.proactiveinvestors.com.au/companies/news/925641/suda-pharmaceuticals-closes-356-million-entitlement-offer-heavily-oversubscribed-925641.html Suda Pharmaceuticals' Dr Michael Baker hails regulatory approval for lead product ZolpiMist https://www.proactiveinvestors.com.au/companies/news/925579/suda-pharmaceuticals--dr-michael-baker-hails-regulatory-approval-for-lead-product-zolpimist-925579.html Fri, 31 Jul 2020 10:47:00 +1000 https://www.proactiveinvestors.com.au/companies/news/925579/suda-pharmaceuticals--dr-michael-baker-hails-regulatory-approval-for-lead-product-zolpimist-925579.html SUDA Pharmaceuticals on hunt for complementary technologies and products to add to current programs https://www.proactiveinvestors.com.au/companies/news/925230/suda-pharmaceuticals-on-hunt-for-complementary-technologies-and-products-to-add-to-current-programs-925230.html Wed, 29 Jul 2020 22:44:00 +1000 https://www.proactiveinvestors.com.au/companies/news/925230/suda-pharmaceuticals-on-hunt-for-complementary-technologies-and-products-to-add-to-current-programs-925230.html SUDA Pharmaceuticals granted TGA approval for short-term insomnia treatment ZolpiMist™ https://www.proactiveinvestors.com.au/companies/news/925291/suda-pharmaceuticals-granted-tga-approval-for-short-term-insomnia-treatment-zolpimist-925291.html Tue, 28 Jul 2020 23:42:00 +1000 https://www.proactiveinvestors.com.au/companies/news/925291/suda-pharmaceuticals-granted-tga-approval-for-short-term-insomnia-treatment-zolpimist-925291.html SUDA Pharmaceuticals will continue advancing oro-mucosal strategy with "constant energy" https://www.proactiveinvestors.com.au/companies/news/924324/suda-pharmaceuticals-will-continue-advancing-oro-mucosal-strategy-with--constant-energy--924324.html Thu, 16 Jul 2020 06:24:00 +1000 https://www.proactiveinvestors.com.au/companies/news/924324/suda-pharmaceuticals-will-continue-advancing-oro-mucosal-strategy-with--constant-energy--924324.html SUDA Pharmaceuticals gets coverage from Edison with 13 cents per share valuation https://www.proactiveinvestors.com.au/companies/news/923675/suda-pharmaceuticals-gets-coverage-from-edison-with-13-cents-per-share-valuation-923675.html Wed, 08 Jul 2020 06:04:00 +1000 https://www.proactiveinvestors.com.au/companies/news/923675/suda-pharmaceuticals-gets-coverage-from-edison-with-13-cents-per-share-valuation-923675.html SUDA Pharmaceuticals raising $3.56 million to further develop oro-mucosal drug delivery assets https://www.proactiveinvestors.com.au/companies/news/923346/suda-pharmaceuticals-raising-356-million-to-further-develop-oro-mucosal-drug-delivery-assets-923346.html Fri, 03 Jul 2020 01:03:00 +1000 https://www.proactiveinvestors.com.au/companies/news/923346/suda-pharmaceuticals-raising-356-million-to-further-develop-oro-mucosal-drug-delivery-assets-923346.html SUDA Pharmaceuticals appoints CEO Dr Michael Baker as new director https://www.proactiveinvestors.com.au/companies/news/922916/suda-pharmaceuticals-appoints-ceo-dr-michael-baker-as-new-director-922916.html Mon, 29 Jun 2020 05:03:00 +1000 https://www.proactiveinvestors.com.au/companies/news/922916/suda-pharmaceuticals-appoints-ceo-dr-michael-baker-as-new-director-922916.html SUDA Pharmaceuticals to continue focus on cancer, insomnia treatments https://www.proactiveinvestors.com.au/companies/news/922724/suda-pharmaceuticals-to-continue-focus-on-cancer-insomnia-treatments-922724.html Thu, 25 Jun 2020 07:17:00 +1000 https://www.proactiveinvestors.com.au/companies/news/922724/suda-pharmaceuticals-to-continue-focus-on-cancer-insomnia-treatments-922724.html SUDA Pharmaceuticals has news upcoming of material licensing and capital raising https://www.proactiveinvestors.com.au/companies/news/920779/suda-pharmaceuticals-has-news-upcoming-of-material-licensing-and-capital-raising-920779.html Mon, 01 Jun 2020 04:52:00 +1000 https://www.proactiveinvestors.com.au/companies/news/920779/suda-pharmaceuticals-has-news-upcoming-of-material-licensing-and-capital-raising-920779.html SUDA Pharmaceuticals encouraged by pharmacokinetic results evaluating anagrelide mouth spray https://www.proactiveinvestors.com.au/companies/news/920451/suda-pharmaceuticals-encouraged-by-pharmacokinetic-results-evaluating-anagrelide-mouth-spray-920451.html Wed, 27 May 2020 00:50:00 +1000 https://www.proactiveinvestors.com.au/companies/news/920451/suda-pharmaceuticals-encouraged-by-pharmacokinetic-results-evaluating-anagrelide-mouth-spray-920451.html SUDA Pharmaceuticals shares rise on securing anagrelide cancer patent in Japan https://www.proactiveinvestors.com.au/companies/news/919997/suda-pharmaceuticals-shares-rise-on-securing-anagrelide-cancer-patent-in-japan-919997.html Wed, 20 May 2020 04:38:00 +1000 https://www.proactiveinvestors.com.au/companies/news/919997/suda-pharmaceuticals-shares-rise-on-securing-anagrelide-cancer-patent-in-japan-919997.html SUDA Pharmaceuticals submits additional data to TGA for ZolpiMist oral spray for insomnia https://www.proactiveinvestors.com.au/companies/news/919317/suda-pharmaceuticals-submits-additional-data-to-tga-for-zolpimist-oral-spray-for-insomnia-919317.html Mon, 11 May 2020 23:47:00 +1000 https://www.proactiveinvestors.com.au/companies/news/919317/suda-pharmaceuticals-submits-additional-data-to-tga-for-zolpimist-oral-spray-for-insomnia-919317.html SUDA Pharmaceuticals progresses ZolpiMist™ commercialisation strategy https://www.proactiveinvestors.com.au/companies/news/918456/suda-pharmaceuticals-progresses-zolpimist-commercialisation-strategy-918456.html Thu, 30 Apr 2020 04:05:00 +1000 https://www.proactiveinvestors.com.au/companies/news/918456/suda-pharmaceuticals-progresses-zolpimist-commercialisation-strategy-918456.html SUDA Pharmaceuticals sets sights on development of oral sprays https://www.proactiveinvestors.com.au/companies/news/917897/suda-pharmaceuticals-sets-sights-on-development-of-oral-sprays-917897.html Wed, 22 Apr 2020 22:44:00 +1000 https://www.proactiveinvestors.com.au/companies/news/917897/suda-pharmaceuticals-sets-sights-on-development-of-oral-sprays-917897.html Suda Pharmaceuticals outlines COVID-19 steps as it continues "doing deals" https://www.proactiveinvestors.com.au/companies/news/916170/suda-pharmaceuticals-outlines-covid-19-steps-as-it-continues--doing-deals--916170.html Tue, 31 Mar 2020 03:16:00 +1100 https://www.proactiveinvestors.com.au/companies/news/916170/suda-pharmaceuticals-outlines-covid-19-steps-as-it-continues--doing-deals--916170.html SUDA Pharmaceuticals grants Mitsubishi Tanabe Korea an exclusive licence for ZolpiMist https://www.proactiveinvestors.com.au/companies/news/915465/suda-pharmaceuticals-grants-mitsubishi-tanabe-korea-an-exclusive-licence-for-zolpimist-915465.html Mon, 23 Mar 2020 06:12:00 +1100 https://www.proactiveinvestors.com.au/companies/news/915465/suda-pharmaceuticals-grants-mitsubishi-tanabe-korea-an-exclusive-licence-for-zolpimist-915465.html SUDA Ltd to reveal agreement https://www.proactiveinvestors.com.au/companies/news/180258/suda-ltd-to-reveal-agreement-180258.html Tue, 04 Jul 2017 01:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/180258/suda-ltd-to-reveal-agreement-180258.html SUDA in deal to develop oro-mucosal spray of anti-cancer agent https://www.proactiveinvestors.com.au/companies/news/179507/suda-in-deal-to-develop-oro-mucosal-spray-of-anti-cancer-agent-179507.html Tue, 20 Jun 2017 06:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/179507/suda-in-deal-to-develop-oro-mucosal-spray-of-anti-cancer-agent-179507.html SUDA to lift cash balance https://www.proactiveinvestors.com.au/companies/news/175959/suda-to-lift-cash-balance-175959.html Tue, 04 Apr 2017 23:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/175959/suda-to-lift-cash-balance-175959.html SUDA moves a step closer to commercialise its spray to fight malaria https://www.proactiveinvestors.com.au/companies/news/175872/suda-moves-a-step-closer-to-commercialise-its-spray-to-fight-malaria-175872.html Mon, 03 Apr 2017 22:30:00 +1000 https://www.proactiveinvestors.com.au/companies/news/175872/suda-moves-a-step-closer-to-commercialise-its-spray-to-fight-malaria-175872.html Suda in an ASX trading halt https://www.proactiveinvestors.com.au/companies/news/172071/suda-in-an-asx-trading-halt-172071.html Tue, 24 Jan 2017 03:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/172071/suda-in-an-asx-trading-halt-172071.html SUDA Limited cements malaria treatment potential https://www.proactiveinvestors.com.au/companies/news/145958/suda-limited-cements-malaria-treatment-potential-64621.html Fri, 18 Sep 2015 08:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/145958/suda-limited-cements-malaria-treatment-potential-64621.html SUDA Limited's migraine treatment on development fast track https://www.proactiveinvestors.com.au/companies/news/145957/suda-limiteds-migraine-treatment-on-development-fast-track-63858.html Thu, 06 Aug 2015 01:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/145957/suda-limiteds-migraine-treatment-on-development-fast-track-63858.html SUDA Limited establishes clinical advisory board for migraine treatment https://www.proactiveinvestors.com.au/companies/news/145956/suda-limited-establishes-clinical-advisory-board-for-migraine-treatment-61888.html Tue, 21 Apr 2015 06:30:00 +1000 https://www.proactiveinvestors.com.au/companies/news/145956/suda-limited-establishes-clinical-advisory-board-for-migraine-treatment-61888.html SUDA Limited to reveal equity raising https://www.proactiveinvestors.com.au/companies/news/145955/suda-limited-to-reveal-equity-raising-61457.html Thu, 26 Mar 2015 07:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/145955/suda-limited-to-reveal-equity-raising-61457.html SUDA negotiates new leads for oro-mucosal drug delivery business https://www.proactiveinvestors.com.au/companies/news/145954/suda-negotiates-new-leads-for-oro-mucosal-drug-delivery-business-61431.html Wed, 25 Mar 2015 03:30:00 +1100 https://www.proactiveinvestors.com.au/companies/news/145954/suda-negotiates-new-leads-for-oro-mucosal-drug-delivery-business-61431.html SUDA working with World Health Organisation for malaria treatment https://www.proactiveinvestors.com.au/companies/news/145953/suda-working-with-world-health-organisation-for-malaria-treatment-57081.html Thu, 21 Aug 2014 07:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/145953/suda-working-with-world-health-organisation-for-malaria-treatment-57081.html SUDA Limited expands activities in WA aged care market https://www.proactiveinvestors.com.au/companies/news/145952/suda-limited-expands-activities-in-wa-aged-care-market-52126.html Wed, 22 Jan 2014 07:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/145952/suda-limited-expands-activities-in-wa-aged-care-market-52126.html Suda raises $5.6M to progress commercialisation of malaria treatment https://www.proactiveinvestors.com.au/companies/news/145951/suda-raises-56m-to-progress-commercialisation-of-malaria-treatment-50134.html Wed, 13 Nov 2013 02:40:00 +1100 https://www.proactiveinvestors.com.au/companies/news/145951/suda-raises-56m-to-progress-commercialisation-of-malaria-treatment-50134.html Suda Limited in pre-open, drug delivery sector https://www.proactiveinvestors.com.au/companies/news/145950/suda-limited-in-pre-open-drug-delivery-sector-50054.html Mon, 11 Nov 2013 04:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/145950/suda-limited-in-pre-open-drug-delivery-sector-50054.html Suda's subsidiary delivers record revenue in September quarter https://www.proactiveinvestors.com.au/companies/news/145949/sudas-subsidiary-delivers-record-revenue-in-september-quarter-49239.html Fri, 18 Oct 2013 00:40:00 +1100 https://www.proactiveinvestors.com.au/companies/news/145949/sudas-subsidiary-delivers-record-revenue-in-september-quarter-49239.html Suda Ltd raises $1.9 million to progress commercialisation of malaria treatment https://www.proactiveinvestors.com.au/companies/news/145948/suda-ltd-raises-19-million-to-progress-commercialisation-of-malaria-treatment-48048.html Mon, 16 Sep 2013 06:20:00 +1000 https://www.proactiveinvestors.com.au/companies/news/145948/suda-ltd-raises-19-million-to-progress-commercialisation-of-malaria-treatment-48048.html Suda Limited to update on acquisition of NovaDel Pharma Inc assets https://www.proactiveinvestors.com.au/companies/news/145947/suda-limited-to-update-on-acquisition-of-novadel-pharma-inc-assets-45808.html Mon, 22 Jul 2013 02:40:00 +1000 https://www.proactiveinvestors.com.au/companies/news/145947/suda-limited-to-update-on-acquisition-of-novadel-pharma-inc-assets-45808.html Suda Limited’s ArTiMist™ shown to be a “superior” malaria treatment for children https://www.proactiveinvestors.com.au/companies/news/145946/suda-limiteds-artimist-shown-to-be-a-superior-malaria-treatment-for-children-42627.html Tue, 30 Apr 2013 01:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/145946/suda-limiteds-artimist-shown-to-be-a-superior-malaria-treatment-for-children-42627.html Suda Limited to release Phase III results for malaria drug https://www.proactiveinvestors.com.au/companies/news/145945/suda-limited-to-release-phase-iii-results-for-malaria-drug-42615.html Mon, 29 Apr 2013 22:30:00 +1000 https://www.proactiveinvestors.com.au/companies/news/145945/suda-limited-to-release-phase-iii-results-for-malaria-drug-42615.html Suda successfully scales up manufacture of malaria treatment spray https://www.proactiveinvestors.com.au/companies/news/145944/suda-successfully-scales-up-manufacture-of-malaria-treatment-spray--42097.html Tue, 16 Apr 2013 05:40:00 +1000 https://www.proactiveinvestors.com.au/companies/news/145944/suda-successfully-scales-up-manufacture-of-malaria-treatment-spray--42097.html Suda to buy NovaDel's NovaMist oral spray formulation technology https://www.proactiveinvestors.com.au/companies/news/145943/suda-to-buy-novadels-novamist-oral-spray-formulation-technology-41711.html Mon, 08 Apr 2013 03:10:00 +1000 https://www.proactiveinvestors.com.au/companies/news/145943/suda-to-buy-novadels-novamist-oral-spray-formulation-technology-41711.html Suda Limited to reveal acquisition https://www.proactiveinvestors.com.au/companies/news/145942/suda-limited-to-reveal-acquisition-37524.html Wed, 19 Dec 2012 05:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/145942/suda-limited-to-reveal-acquisition-37524.html